Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Hendrix

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Lipidology|August 7, 2023
A new SPRING in lipid metabolismSebastian Hendrix, Noam Zelcer
International Journal of Molecular Sciences|January 30, 2020
Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 AxisIlaria Del Gaudio, Sebastian Hendrix, Christina Christoffersen, et al.
Nature Communications|July 8, 2024
SPRING licenses S1P-mediated cleavage of SREBP2 by displacing an inhibitory pro-domainSebastian Hendrix, Vincent Dartigue, Hailee Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2025
Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitorAshley V Bullington, Ilaria Micallo, Bilkish Bajaj, et al.
Molecular and Cellular Biology|May 15, 2024
SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1PSebastian Hendrix, Josephine M E Tan, Klevis Ndoj, et al.
The EMBO Journal|October 21, 2024
Glutamine sensing licenses cholesterol synthesisBruna Martins Garcia, Philipp Melchinger, Tania Medeiros, et al.
Thrombosis and Haemostasis|December 1, 2021
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage PolarityJamie Kane, Matthijs Jansen, Sebastian Hendrix, et al.
Nature Communications|August 25, 2023
Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humansSebastian Hendrix, Jenina Kingma, Roelof Ottenhoff, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Nature Communications|March 1, 2020
Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolismAnke Loregger, Matthijs Raaben, Joppe Nieuwenhuis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Lipidology|August 7, 2023
A new SPRING in lipid metabolismSebastian Hendrix, Noam Zelcer
International Journal of Molecular Sciences|January 30, 2020
Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 AxisIlaria Del Gaudio, Sebastian Hendrix, Christina Christoffersen, et al.
Nature Communications|July 8, 2024
SPRING licenses S1P-mediated cleavage of SREBP2 by displacing an inhibitory pro-domainSebastian Hendrix, Vincent Dartigue, Hailee Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2025
Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitorAshley V Bullington, Ilaria Micallo, Bilkish Bajaj, et al.
Molecular and Cellular Biology|May 15, 2024
SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1PSebastian Hendrix, Josephine M E Tan, Klevis Ndoj, et al.
The EMBO Journal|October 21, 2024
Glutamine sensing licenses cholesterol synthesisBruna Martins Garcia, Philipp Melchinger, Tania Medeiros, et al.
Thrombosis and Haemostasis|December 1, 2021
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage PolarityJamie Kane, Matthijs Jansen, Sebastian Hendrix, et al.
Nature Communications|August 25, 2023
Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humansSebastian Hendrix, Jenina Kingma, Roelof Ottenhoff, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Nature Communications|March 1, 2020
Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolismAnke Loregger, Matthijs Raaben, Joppe Nieuwenhuis, et al.
Pageof 2